, Volume 47, Supplement 4, pp 25–30 | Cite as

Exercise Testing as Outcome in Congestive Heart Failure Trials

Design Considerations When Interpreting Results
  • J. Lubsen


In addition to standard features of clinical trial design such as randomisation and double-blinding, sensitivity to drug effects is an important consideration when conducting exercise capacity trials in patients with heart failure. Two issues need to be addressed in this context. Firstly, it is important to enrol patients who are potential responders. Patients who have, for their age and sex, normal exercise capacity are unlikely to improve, even when given a drug that has a positive effect on exercise capacity. In addition, those patients who remain clinically stable following withdrawal of their previous drug therapy are unlikely to respond subsequently to an experimental drug with a similar mechanism of action. Secondly, failure to complete scheduled exercise tests during follow-up, prompting a ‘per-protocol’ analysis of results, may mask the drug’s actual effect. To avoid this, an ‘intention-to-treat’ approach to data collection and analysis, with appropriate allowance made for missing test data, should be adopted.


Exercise Test Exercise Capacity Clinical Trial Design Heart Failure Trial Improve Exercise Capacity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Gardner MJ, Altman DG. Statistics in medicine: confidence intervals rather than p values, estimation rather than hypothesis testing. British Medical Journal 292: 746–750, 1986.PubMedCrossRefGoogle Scholar
  2. Löllgen H, Ulmer H-V, Crean P for the ICSSPE Working Group on Ergometry. Recommendations and standard guidelines for exercise testing: a report of the Task Force Conference on Ergometry. European Heart Journal 88 (Suppl. K): 3–37, 1988Google Scholar
  3. Swedberg K. Exercise testing in heart failure, a critical review. Drugs 47 (Suppl. 4): 14–24, 1994PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • J. Lubsen
    • 1
    • 2
  1. 1.Société pour la Recherche Cardiologique SOCAR SAGivrinsSwitzerland
  2. 2.Erasmus UniversityRotterdamThe Netherlands

Personalised recommendations